BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22209114)

  • 1. Impact of valproic acid on dendritic cells function.
    Frikeche J; Simon T; Brissot E; Grégoire M; Gaugler B; Mohty M
    Immunobiology; 2012 Jul; 217(7):704-10. PubMed ID: 22209114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function.
    Arbez J; Lamarthée B; Gaugler B; Saas P
    Immunobiology; 2014 Aug; 219(8):637-43. PubMed ID: 24742998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide stimulation converts vigorously washed dendritic cells (DCs) to nonexhausted DCs expressing CD70 and evoking long-lasting type 1 T cell responses.
    Iwamoto S; Ishida M; Takahashi K; Takeda K; Miyazaki A
    J Leukoc Biol; 2005 Aug; 78(2):383-92. PubMed ID: 15857939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
    Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
    Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
    Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinomenine promotes differentiation but impedes maturation and co-stimulatory molecule expression of human monocyte-derived dendritic cells.
    Chen Y; Yang C; Jin N; Xie Z; Fei L; Jia Z; Wu Y
    Int Immunopharmacol; 2007 Aug; 7(8):1102-10. PubMed ID: 17570327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
    Peiser M; Wanner R; Kolde G
    J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
    von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
    J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
    Repnik U; Bergant M; Wraber B; Jeras M
    Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of suppressive phenotype in monocyte-derived dendritic cells by leukemic cell products and IL-1β.
    Motta JM; Sperandio A; Castelo-Branco MT; Rumjanek VM
    Hum Immunol; 2014 Jul; 75(7):641-9. PubMed ID: 24768898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
    Kurlander RJ; Tawab A; Fan Y; Carter CS; Read EJ
    Transfusion; 2006 Sep; 46(9):1494-504. PubMed ID: 16965575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.
    Zobywalski A; Javorovic M; Frankenberger B; Pohla H; Kremmer E; Bigalke I; Schendel DJ
    J Transl Med; 2007 Apr; 5():18. PubMed ID: 17430585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
    Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma.
    Nakahara T; Urabe K; Fukagawa S; Uchi H; Inaba K; Furue M; Moroi Y
    Clin Exp Immunol; 2005 Mar; 139(3):476-82. PubMed ID: 15730393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.